Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation

Starting soon · Not applicable

Conditions studied: Anemia Complicating Pregnancy

In brief

This study aims to address this evidence gap by comparing a step-up oral-first strategy with an early IV iron strategy in pregnant women diagnosed with anemia after 34 weeks of gestation.

Key facts

Study ID

NCT07485023

Run by

University of Roma La Sapienza

People needed

128

Starts

2026-07-01

Expected to finish

2028-09-01

Last updated by the study team

2026-03-20

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• • Women aged 18 years or older.
• Singleton pregnancy.
• Gestational age ≥34+0 weeks at the time of anemia diagnosis.
• Hemoglobin <11 g/dL measured as part of routine antenatal care.
• Ongoing antenatal follow-up at Policlinico Umberto I.
• Ability to understand study procedures and provide written informed consent.

You may not qualify if…

• • Known anemia not primarily due to iron deficiency.
• Known hemoglobinopathies.
• Severe anemia requiring immediate blood transfusion.
• Previous severe hypersensitivity reaction to IV iron formulations.
• Chronic hematologic disease.
• Acute infection or inflammatory condition at enrollment.
• Severe hepatic or renal impairment.
• Any condition judged by the investigator to make participation unsafe.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.